PortfoliosLab logoPortfoliosLab logo
VCOB vs. ARKG
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

VCOB vs. ARKG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Voya Core Bond ETF (VCOB) and ARK Genomic Revolution Multi-Sector ETF (ARKG). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, VCOB achieves a -2.21% return, which is significantly lower than ARKG's 29.44% return.


VCOB

1D
-0.33%
1M
-1.76%
6M
-2.50%
YTD
-2.21%
1Y
3Y*
5Y*
10Y*
ALL TIME*

ARKG

1D
-0.85%
1M
-11.47%
6M
19.12%
YTD
29.44%
1Y
52.32%
3Y*
0.19%
5Y*
-14.86%
10Y*
7.89%
ALL TIME*
5.94%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$103.82M$130.27M$121.59M
$300.60K$226.80K$472.29K

VCOB vs. ARKG - Yearly Performance Comparison


2026 (YTD)2025
VCOB
Voya Core Bond ETF
-2.21%0.35%
ARKG
ARK Genomic Revolution Multi-Sector ETF
29.44%7.90%

Correlation

The correlation between VCOB and ARKG is 0.42, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (All Time)
Calculated using the full available price history since Nov 19, 2025

0.42

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

VCOB vs. ARKG — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

VCOB

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.


ARKG
ARKG Risk / Return Rank: 5050
Overall Rank
ARKG Sharpe Ratio Rank: 5050
Sharpe Ratio Rank
ARKG Sortino Ratio Rank: 5555
Sortino Ratio Rank
ARKG Omega Ratio Rank: 4747
Omega Ratio Rank
ARKG Calmar Ratio Rank: 5454
Calmar Ratio Rank
ARKG Martin Ratio Rank: 4242
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

VCOB vs. ARKG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Voya Core Bond ETF (VCOB) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


VCOBARKGDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.22

Calmar ratioReturn relative to maximum drawdown

1.91

Martin ratioReturn relative to average drawdown

4.59

VCOB vs. ARKG - Sharpe Ratio Comparison


Loading charts...

Drawdowns

VCOB vs. ARKG - Drawdown Comparison

The maximum VCOB drawdown since its inception was -3.53%, smaller than the maximum ARKG drawdown of -83.59%. Use the drawdown chart below to compare losses from any high point for VCOB and ARKG.


Loading charts...

Drawdown Indicators


VCOBARKGDifference

Max Drawdown

Largest peak-to-trough decline

-3.53%

-83.59%

+80.06%

Max Drawdown (1Y)

Largest decline over 1 year

-27.51%

Max Drawdown (3Y)

Largest decline over 3 years

-51.74%

Max Drawdown (5Y)

Largest decline over 5 years

-79.26%

Max Drawdown (10Y)

Largest decline over 10 years

-83.59%

Current Drawdown

Current decline from peak

-3.52%

-66.45%

+62.93%

Average Drawdown

Average peak-to-trough decline

-1.53%

-36.25%

+34.72%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.44%

Volatility

VCOB vs. ARKG - Volatility Comparison


Loading charts...

Volatility by Period


VCOBARKGDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.17%

Volatility (6M)

Calculated over the trailing 6-month period

31.06%

Volatility (1Y)

Calculated over the trailing 1-year period

3.82%

43.05%

-39.23%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

3.82%

46.14%

-42.32%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

3.82%

41.42%

-37.60%

VCOB vs. ARKG - Expense Ratio Comparison

VCOB has a 0.25% expense ratio, which is lower than ARKG's 0.75% expense ratio.


Dividends

VCOB vs. ARKG - Dividend Comparison

VCOB's dividend yield for the trailing twelve months is around 0.50%, while ARKG has not paid dividends to shareholders.


PositionTTM202520242023202220212020201920182017
ARKG
ARK Genomic Revolution Multi-Sector ETF
0.00%0.00%0.00%0.00%0.00%0.62%0.85%3.14%0.82%1.34%
VCOB
Voya Core Bond ETF
0.50%0.49%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


VCOB and ARKG have a correlation of 0.42, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, VCOB is cheaper at 0.25% per year. The better choice depends on whether you care most about return, fees, risk, or income.

VCOB is cheaper with a 0.25% expense ratio, compared with 0.75% for ARKG.

VCOB has the higher dividend yield at 0.50%, compared with 0.00% for ARKG.

VCOB is categorized as Actively Managed, while ARKG is Health & Biotech Equities. They also come from different issuers: Voya and ARK. Their fees differ too: 0.25% for VCOB and 0.75% for ARKG.

Portfolio Optimizer

Find the right allocation for VCOB and ARKG

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer